Chronic lymphocytic leukaemia trials in Belarus
1 of 2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleObserv Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus
- Where
- Grodno, Homyel, Minsk, Mogilev
- Age
- 18 years and over
- People
- 50
- Run by
- AstraZeneca
See details and how to joinNCT07288515